-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GadqIajJqh07A6av1bO/YW4mtWNZ6CK5gwxiDx8Hw19uau4ZnUUMsQ+KpHWxKwCx Bi0bzNPLKV9G8lyIZ85q+g== 0001209191-10-005683.txt : 20100201 0001209191-10-005683.hdr.sgml : 20100201 20100201111257 ACCESSION NUMBER: 0001209191-10-005683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100128 FILED AS OF DATE: 20100201 DATE AS OF CHANGE: 20100201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhao Yanping CENTRAL INDEX KEY: 0001430966 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32980 FILM NUMBER: 10562235 MAIL ADDRESS: STREET 1: C/O BMP SUNSTONE CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BMP Sunstone CORP CENTRAL INDEX KEY: 0001281696 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 200434726 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 W. GERMANTOWN PIKE STREET 2: SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 610-940-1675 MAIL ADDRESS: STREET 1: 600 W. GERMANTOWN PIKE STREET 2: SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: BEIJING MED PHARM CORP DATE OF NAME CHANGE: 20040225 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-01-28 0 0001281696 BMP Sunstone CORP BJGP 0001430966 Zhao Yanping 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462 0 1 0 0 Corporate Vice President Stock option (right to buy) 5.42 2010-01-28 4 A 0 100000 A 2020-01-28 Common stock 100000 245000 D Vesting schedule: 25% on January 28, 2011; 1/36th on the 1st of every month thereafter. Not applicable. Fred M. Powell, By Power of Attorney 2010-02-01 EX-24.4_314570 2 poa.txt POA DOCUMENT LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS The undersigned hereby constitutes and appoints each of David Gao and Fred Powell her true and lawful attorneys-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or executive officer of Beijing Med-Pharm Corporation (the "Company"), as applicable, Forms 3, 4 or 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Form 3, 4, or 5 and the timely filing of such form with the United States Securities and Exchange Commission and any other authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorneys-in-fact may approve in their discretion. The undersigned hereby grants to such attorneys-in-fact full power and authority to do and perform every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or their substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on the 1st day of October, 2007. /s/Yanping Zhao -----END PRIVACY-ENHANCED MESSAGE-----